Pleural mesothelioma and lung cancer: the role of asbestos exposure and genetic variants in selected iron metabolism and inflammation genes

References

• Andrade, C. 2015. Understanding relative risk, odds ratio, and related terms: As simple as it can get. J. Clin. Psychiat. 76:e857–861. doi:10.4088/JCP.15f10150.
   PubMed Web of Science ®Google Scholar
• Andujar, P., A. Lacourt, P. Brochard, J.-C. Pairon, M.-C. Jaurand, and D. Jean. 2016. Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles. J. Toxicol Environ. Health B 19:151–72. doi:10.1080/10937404.2016.1193361.
   PubMed Web of Science ®Google Scholar
• Anonymous. 2015. RStudio: Integrated development for r. rstudio, inc. http://www.rstudio.com/.
   Google Scholar
• Ather, J. L., R. A. Martin, K. Ckless, and M. E. Poynter. 2014. Inflammasome activity in non-microbial lung inflammation. J. Environ. Immunol. Toxicol. 1:108–17.
   PubMedGoogle Scholar
• Aust, A. E., P. M. Cook, and R. F. Dodson. 2011. Morphological and chemical mechanisms of elongated mineral particle toxicities. J. Toxicol Environ. Health B 14:40–75. doi:10.1080/10937404.2011.556046.
   PubMed Web of Science ®Google Scholar
• Aust, E. A., L. G. Lund, C. C. Chao, S. H. Park, and R. Fang. 2000. Role of iron in the cellular effects of asbestos. Inhal Toxicol 12 (Suppl 3):75–80. doi:10.1080/08958378.2000.11463232.
   PubMedGoogle Scholar
• Baumann, F., J. P. Ambrosi, and M. Carbone. 2013. Asbestos is not just asbestos: An unrecognised health hazard. Lancet Oncol. 14:576–78. doi:10.1016/S1470-2045(13)70257-2.
   PubMed Web of Science ®Google Scholar
• Betti, M., A. Aspesi, D. Ferrante, M. Sculco, L. Righi, D. Mirabelli, F. Napoli, M. Rondón-Lagos, E. Casalone, F. Vignolo Lutati, et al. 2018. Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in bap1 or other DNA repair genes. Genes Chromosomes Cancer 57:573–83. doi:10.1002/gcc.22670.
   PubMed Web of Science ®Google Scholar
• Betti, M., A. Aspesi, M. Sculco, G. Matullo, C. Magnani, and I. Dianzani. 2019. Genetic predisposition for malignant mesothelioma: A concise review. Mutat. Res/Rev Mutat. Res. 781:1–10. doi:10.1016/j.mrrev.2019.03.001.
   PubMed Web of Science ®Google Scholar
• Betti, M., E. Casalone, D. Ferrante, A. Aspesi, G. Morleo, A. Biasi, M. Sculco, G. Mancuso, S. Guarrera, L. Righi, et al. 2017. Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma. Cancer Lett. 405:38–45. doi:10.1016/j.canlet.2017.06.028.
   PubMed Web of Science ®Google Scholar
• Bianchi, C., A. Brollo, L. Ramani, and R. Berté. 1991. Exposure to asbestos in Monfalcone, Italy. A necropsy-based study. IARC Sci. Publ. 112:127–40.
   Google Scholar
• Bianchi, C., A. Brollo, L. Ramani, and C. Zuch. 1993. Asbestos-related mesothelioma in Monfalcone, Italy. Am. J. Ind. Med. 24:149–60. doi:10.1002/ajim.4700240203.
   PubMed Web of Science ®Google Scholar
• Bianchi, C., and T. Bianchi. 2007. Malignant mesothelioma: Global incidence and relationship with asbestos. Ind Health 45:379–87. doi:10.2486/indhealth.45.379.
   PubMed Web of Science ®Google Scholar
• Bisel, H. F., F. Wroblewski, and J. S. Ladue. 1953. Incidence and clinical manifestations of cardiac metastases. J. Am. Med. Assoc. 153:712–15. doi:10.1001/jama.1953.02940250018005.
   PubMed Web of Science ®Google Scholar
• Borelli, V., C. Brochetta, M. Melato, C. Rizzardi, M. Polentarutti, C. Busatto, F. Vita, R. Abbate, R. Gotter, and G. Zabucchi. 2007. A procedure for the isolation of asbestos bodies from lung tissue by exploiting their magnetic properties: A new approach to asbestos body study. J. Toxicol. Environ. Health A 70:1232–40. doi:10.1080/15287390701380906.
   PubMed Web of Science ®Google Scholar
• Borelli, V., R. R. Moura, E. Trevisan, and S. Crovella. 2015. NLRP1 and NLRP3 polymorphisms in mesothelioma patients and asbestos exposed individuals a population-based autopsy study from north east Italy. Infect. Agents Cancer 10:26. doi:10.1186/s13027-015-0022-0.
   PubMed Web of Science ®Google Scholar
• Bueno, R., E. W. Stawiski, L. D. Goldstein, S. Durinck, A. De Rienzo, Z. Modrusan, F. Gnad, T. T. Nguyen, B. S. Jaiswal, L. R. Chirieac, et al. 2016. Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations. Nat. Genet. 48:407–16. doi:10.1038/ng.3520.
   PubMed Web of Science ®Google Scholar
• Cadby, G., S. Mukherjee, A. W. B. Musk, A. Reid, M. Garlepp, I. Dick, C. Robinson, J. Hui, G. Fiorito, S. Guarrera, et al. 2013. A genome-wide association study for malignant mesothelioma risk. Lung Cancer 82:1–8. doi:10.1016/j.lungcan.2013.04.018.
   PubMed Web of Science ®Google Scholar
• Carbone, M., P. S. Adusumilli, H. R. Alexander, P. Baas, F. Bardelli, A. Bononi, R. Bueno, E. Felley‐Bosco, F. Galateau‐Salle, D. Jablons, et al. 2019. Mesothelioma: Scientific clues for prevention, diagnosis, and therapy. CA Cancer J. Clin. 69:402–29. doi:10.3322/caac.21572.
   PubMed Web of Science ®Google Scholar
• Carbone, M., Y. I. Baris, P. Bertino, B. Brass, S. Comertpay, A. U. Dogan, G. Gaudino, S. Jube, S. Kanodia, C. R. Partridge, et al. 2011. Erionite exposure in North Dakota and Turkish villages with mesothelioma. Proc. Natl. Acad. Sci. 108:13618–23. doi:10.1073/pnas.1105887108.
   PubMed Web of Science ®Google Scholar
• Carbone, M., L. K. Ferris, F. Baumann, A. Napolitano, C. A. Lum, E. G. Flores, G. Gaudino, A. Powers, P. Bryant-Greenwood, T. Krausz, et al. 2012. BAP1 cancer syndrome: Malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J. Transl. Med. 10:179. doi:10.1186/1479-5876-10-179.
   PubMed Web of Science ®Google Scholar
• Carbone, M., and H. Yang. 2012. Molecular pathways: Targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma. Clin. Cancer Res. 18:598–604. doi:10.1158/1078-0432.CCR-11-2259.
   PubMed Web of Science ®Google Scholar
• Carbone, M., H. Yang, H. I. Pass, T. Krausz, J. R. Testa, and G. Gaudino. 2013. BAP1 and cancer. Nat. Rev. Cancer 13:153–59. doi:10.1038/nrc3459.
   PubMed Web of Science ®Google Scholar
• Casali, M., M. Carugno, A. Cattaneo, D. Consonni, C. Mensi, U. Genovese, D. M. Cavallo, A. Somigliana, and A. C. Pesatori. 2015. Asbestos lung burden in necroscopic samples from the general population of Milan, Italy. Ann. Occup. Hyg. 59:909–21. doi:10.1093/annhyg/mev028.
   PubMed Web of Science ®Google Scholar
• Chew, S. H., and S. Toyokuni. 2015. Malignant mesothelioma as an oxidative stress-induced cancer: An update. Free Radic. Biol. Med. 86:166–78. doi:10.1016/j.freeradbiomed.2015.05.002.
   PubMed Web of Science ®Google Scholar
• Christiani, D. C. 2000. Smoking and the molecular epidemiology of lung cancer. Clin. Chest Med. 21:87–93. doi:10.1016/S0272-5231(05)70009-5.
   PubMed Web of Science ®Google Scholar
• Clayton, D. G. 2009. Sex chromosomes and genetic association studies. Genome Med 1:110. doi:10.1186/gm110.
   PubMed Web of Science ®Google Scholar
• Crovella, S., R. R. Moura, S. Cappellani, F. Celsi, E. Trevisan, M. Schneider, A. Brollo, E. M. Nicastro, F. Vita, L. Finotto, et al. 2018. A genetic variant of nlrp1 gene is associated with asbestos body burden in patients with malignant pleural mesothelioma. J. Toxicol. Environ. Health A 81:98–105. doi:10.1080/15287394.2017.1416911.
   PubMed Web of Science ®Google Scholar
• Crovella, S., A. M. Bianco, J. Vuch, L. Zupin, R. R. Moura, E. Trevisan, M. Schneider, A. Brollo, E. M. Nicastro, A. Cosenzi, et al. 2016. Iron signature in asbestos-induced malignant pleural mesothelioma: A population-based autopsy study. J. Toxicol. Environ. Health A 79:129–41. doi:10.1080/15287394.2015.1123452.
   PubMed Web of Science ®Google Scholar
• Dianzani, I., L. Gibello, A. Biava, M. Giordano, M. Bertolotti, M. Betti, D. Ferrante, S. Guarrera, G. P. Betta, D. Mirabelli, et al. 2006. Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study. Mutat. Res. 599:124–34. doi:10.1016/j.mrfmmm.2006.02.005.
   PubMed Web of Science ®Google Scholar
• Dostert, C., V. Pétrilli, R. Van Bruggen, C. Steele, B. T. Mossman, and J. Tschopp. 2008. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320:674–77. doi:10.1126/science.1156995.
   PubMed Web of Science ®Google Scholar
• Faul, F., E. Erdfelder, A. Buchner, and A.-G. Lang. 2009. Statistical power analyses using g*power 3.1: Tests for correlation and regression analyses. Behav. Res. Meth. 41:1149–60. doi:10.3758/BRM.41.4.1149.
   PubMed Web of Science ®Google Scholar
• Gemignani, F., M. Neri, F. Bottari, R. Barale, P. A. Canessa, F. Canzian, M. Ceppi, I. Spitaleri, M. Cipollini, G. P. Ivaldi, et al. 2009. Risk of malignant pleural mesothelioma and polymorphisms in genes involved in the genome stability and xenobiotics metabolism. Mutat. Res. 671:76–83. doi:10.1016/j.mrfmmm.2009.09.003.
   PubMed Web of Science ®Google Scholar
• Ghio, A. J., E. D. Hilborn, J. G. Stonehuerner, L. A. Dailey, J. D. Carter, J. H. Richards, K. M. Crissman, R. F. Foronjy, D. L. Uyeminami, and K. E. Pinkerton. 2008. Particulate matter in cigarette smoke alters iron homeostasis to produce a biological effect. Am. J. Respir. Crit. Care Med. 178:1130–38. doi:10.1164/rccm.200802-334OC.
   PubMed Web of Science ®Google Scholar
• Ghio, A. J., E. N. Pavlisko, and V. L. Roggli. 2015. Iron and iron-related proteins in asbestosis. J. Environ. Pathol. Toxicol. Oncol. 34:277–85. doi:10.1615/JEnvironPatholToxicolOncol.v34.i4.
   PubMed Web of Science ®Google Scholar
• Gilham, C., C. Rake, G. Burdett, A. G. Nicholson, L. Davison, A. Franchini, J. Carpenter, J. Hodgson, A. Darnton, and J. Peto. 2016. Pleural mesothelioma and lung cancer risks in relation to occupational history and asbestos lung burden. Occup. Environ. Med. 73:290–99. doi:10.1136/oemed-2015-103074.
   PubMed Web of Science ®Google Scholar
• Girardelli, M., I. Maestri, R. R. Rinaldi, M. Tognon, R. Boldorini, M. Bovenzi, S. Crovella, and M. Comar. 2012. NLRP1 polymorphisms in patients with asbestos-associated mesothelioma. Infect. Agents Cancer 7:25. doi:10.1186/1750-9378-7-25.
   PubMed Web of Science ®Google Scholar
• Graffelman, J. 2015. Exploring diallelic genetic markers: The HardyWeinberg package. J. Stat. Software 64:1–23. doi:10.18637/jss.v064.i03.
   Web of Science ®Google Scholar
• Hayward, J. A., A. Mathur, C. Ngo, and S. M. Man. 2018. Cytosolic recognition of microbes and pathogens: Inflammasomes in action. Microbiol. Mol. Biol. Rev. 82. doi:10.1128/MMBR.00015-18.
   Web of Science ®Google Scholar
• Hillegass, J. M., J. M. Miller, M. B. MacPherson, C. M. Westbom, M. Sayan, J. K. Thompson, S. L. Macura, T. N. Perkins, S. L. Beuschel, V. Alexeeva, et al. 2013. Asbestos and erionite prime and activate the NLRP3 inflammasome that stimulates autocrine cytokine release in human mesothelial cells. Part Fibre Toxicol 10:39. doi:10.1186/1743-8977-10-39.
   PubMed Web of Science ®Google Scholar
• Hirvonen, A., S. T. Saarikoski, K. Linnainmaa, K. Koskinen, K. Husgafvel-Pursiainen, K. Mattson, and H. Vainio. 1996. Glutathione s-transferase and n-acetyltransferase genotypes and asbestos-associated pulmonary disorders. J. Natl. Cancer Inst. 88 (24):1853–56. doi:10.1093/jnci/88.24.1853.
   PubMedGoogle Scholar
• Inai, K. 2008. Pathology of mesothelioma. Environ. Health Prev. Med. 13:60–64. doi:10.1007/s12199-007-0017-6.
   PubMedGoogle Scholar
• International Agency for Research on Cancer, and Weltgesundheitsorganisation, eds. 2012. IARC monographs on the evaluation of carcinogenic risks to humans, volume 100 C, arsenic, metals, fibres, and dusts: This publication represents the views and expert opinions of an IARC working group on the evaluation of carcinogenic risks to humans, which met in Lyon, 17–24 March 2009. Lyon: IARC. ISBN-13: 978-9283213208.
   Google Scholar
• Jiang, L., S. Akatsuka, H. Nagai, S.-H. Chew, H. Ohara, Y. Okazaki, Y. Yamashita, Y. Yoshikawa, H. Yasui, K. Ikuta, et al. 2012. Iron overload signature in chrysotile-induced malignant mesothelioma. J. Pathol. 228:366–77. doi:10.1002/path.4075.
   PubMed Web of Science ®Google Scholar
• Kamp, D. W. 2009. Asbestos-induced lung diseases: An update. Transl Res 153:143–52. doi:10.1016/j.trsl.2009.01.004.
   PubMed Web of Science ®Google Scholar
• Kamp, D. W., and S. A. Weitzman. 1999. The molecular basis of asbestos induced lung injury. Thorax 54:638–52. doi:10.1146/annurev-pathol-020712-163942.
   PubMed Web of Science ®Google Scholar
• Kettunen, E., H. Hernandez-Vargas, M.-P. Cros, G. Durand, F. Le Calvez-Kelm, K. Stuopelyte, S. Jarmalaite, K. Salmenkivi, S. Anttila, H. Wolff, et al. 2017. Asbestos-associated genome-wide DNA methylation changes in lung cancer. Int. J. Cancer 141 (10):2014–29. doi:10.1002/ijc.30897.
   PubMed Web of Science ®Google Scholar
• Kong, H., Y. Wang, X. Zeng, Z. Wang, H. Wang, and W. Xie. 2015. Differential expression of inflammasomes in lung cancer cell lines and tissues. Tumour Biol. 36:7501–13. doi:10.1007/s13277-015-3473-4.
   PubMedGoogle Scholar
• Landi, S., F. Gemignani, M. Neri, R. Barale, S. Bonassi, F. Bottari, P. A. Canessa, F. Canzian, M. Ceppi, R. Filiberti, et al. 2007. Polymorphisms of glutathione-s-transferase M1 and manganese superoxide dismutase are associated with the risk of malignant pleural mesothelioma. Int. J. Cancer 120:2739–43. doi:10.1002/ijc.22590.
   PubMed Web of Science ®Google Scholar
• Le Calvez, F., A. Mukeria, J. D. Hunt, O. Kelm, R. J. Hung, P. Tanière, P. Brennan, P. Boffetta, D. G. Zaridze, and P. Hainaut. 2005. TP53 and KRas mutation load and types in lung cancers in relation to tobacco smoke: Distinct patterns in never, former, and current smokers. Cancer Res. 65:5076–83. doi:10.1158/0008-5472.CAN-05-0551.
   PubMed Web of Science ®Google Scholar
• Lemen, R. A. 2016. Mesothelioma from asbestos exposures: Epidemiologic patterns and impact in the United States. J. Toxicol Environ. Health B 19:250–65. doi:10.1080/10937404.2016.1195323.
   PubMed Web of Science ®Google Scholar
• Lewis, C. M., and J. Knight. 2012. Introduction to genetic association studies. Cold Spring Harb. Protoc. 2012:297–306. doi:10.1101/pdb.top068163.
   PubMedGoogle Scholar
• Liu, C.-Y., I. Stücker, C. Chen, G. Goodman, M. K. McHugh, A. M. D’Amelio, C. J. Etzel, S. Li, X. Lin, and D. C. Christiani. 2015. Genome-wide gene-asbestos exposure interaction association study identifies a common susceptibility variant on 22q13.31 associated with lung cancer risk. Cancer Epidemiol. Biomarkers Prev. 24:1564–73. doi:10.1158/1055-9965.EPI-15-0021.
   PubMed Web of Science ®Google Scholar
• London, S. J., A. K. Daly, J. Cooper, W. C. Navidi, C. L. Carpenter, and J. R. Idle. 1995. Polymorphism of glutathione s-transferase m1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. J. Natl. Cancer Inst. 87:1246–53. doi:10.1093/jnci/87.16.1246.
   PubMed Web of Science ®Google Scholar
• Markowitz, S. B., S. M. Levin, A. Miller, and A. Morabia. 2013. Asbestos, asbestosis, smoking, and lung cancer. New findings from the North American insulator cohort. Am. J. Respir. Crit. Care Med. 188:90–96. doi:10.1164/rccm.201302-0257OC.
   PubMed Web of Science ®Google Scholar
• Martinon, F., K. Burns, and J. Tschopp. 2002. The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell. 10:417–26. doi:10.1016/s1097-2765(02)00599-3.
   PubMed Web of Science ®Google Scholar
• Matullo, G., S. Guarrera, M. Betti, G. Fiorito, D. Ferrante, F. Voglino, G. Cadby, C. Di Gaetano, F. Rosa, A. Russo, et al. 2013. Genetic variants associated with increased risk of malignant pleural mesothelioma: A genome-wide association study. PLoS ONE 8:e61253. doi:10.1371/journal.pone.0061253.
   PubMedGoogle Scholar
• Mossman, B. T., A. Shukla, N. H. Heintz, C. F. Verschraegen, A. Thomas, and R. Hassan. 2013. New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas. Am. J. Pathol. 182:1065–77. doi:10.1016/j.ajpath.2012.12.028.
   PubMed Web of Science ®Google Scholar
• Mossman, B. T. 1990. In vitro studies on the biologic effects of fibers: Correlation with in vivo bioassays. Environ. Health Perspect. 88:319–22. doi:10.1289/ehp.9088319.
   PubMed Web of Science ®Google Scholar
• Mossman, B. T., and A. Churg. 1998. Mechanisms in the pathogenesis of asbestosis and silicosis. Am. J. Respir. Crit. Care Med. 157:1666–80. doi:10.1164/ajrccm.157.5.9707141.
   PubMed Web of Science ®Google Scholar
• Murakami, A., Y. Fujimori, Y. Yoshikawa, S. Yamada, K. Tamura, N. Hirayama, T. Terada, K. Kuribayashi, C. Tabata, K. Fukuoka, et al. 2012. Heme oxygenase-1 promoter polymorphism is associated with risk of malignant mesothelioma. Lung 190:333–37. doi:10.1016/j.ajpath.2012.12.028.
   PubMed Web of Science ®Google Scholar
• Neri, M., D. Ugolini, I. Dianzani, F. Gemignani, S. Landi, A. Cesario, C. Magnani, L. Mutti, R. Puntoni, and S. Bonassi. 2008. Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases. Mutat. Res. 659:126–36. doi:10.1016/j.mrrev.2008.02.002.
   PubMed Web of Science ®Google Scholar
• Norton, E. C., B. E. Dowd, and M. L. Maciejewski. 2018. Odds ratios—Current best practice and use. J. Am. Med. Assoc. 320:84–85. doi:10.1001/jama.2018.6971.
   PubMed Web of Science ®Google Scholar
• Ohar, J. A., M. Cheung, J. Talarchek, S. E. Howard, T. D. Howard, M. Hesdorffer, H. Peng, F. J. Rauscher, and J. R. Testa. 2016. Germline Bap1 mutational landscape of asbestos-exposed malignant mesothelioma patients with family history of cancer. Cancer Res. 76:206–15. doi:10.1158/0008-5472.CAN-15-0295.
   PubMed Web of Science ®Google Scholar
• Pascolo, L., G. Zabucchi, A. Gianoncelli, G. Kourousias, E. Trevisan, E. Pascotto, C. Casarsa, C. Ryan, M. Lucattelli, G. Lungarella, et al. 2016. Synchrotron x-ray microscopy reveals early calcium and iron interaction with crocidolite fibers in the lung of exposed mice. Toxicol. Lett. 241:111–20. doi:10.1016/j.toxlet.2015.11.016.
   PubMed Web of Science ®Google Scholar
• Ruda, T. A., and P. K. Dutta. 2005. Fenton chemistry of Fe(III)-exchanged zeolitic minerals treated with antioxidants. Environ. Sci. Technol. 39:6147–52. doi:10.1021/es050336e.
   PubMed Web of Science ®Google Scholar
• Schabath, M. B., M. R. Spitz, G. L. Delclos, G. B. Gunn, L. W. Whitehead, and X. Wu. 2002. Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk. Am. J. Ind. Med. 42:29–37. doi:10.1002/ajim.10084.
   PubMed Web of Science ®Google Scholar
• Schneider, J., and U. Bernges. 2009. CYP1A1 and cyp1b1 polymorphisms as modifying factors in patients with pneumoconiosis and occupationally related tumours: A pilot study. Mol. Med. Rep. 2:1023–28. doi:10.3892/mmr_00000209.
   PubMed Web of Science ®Google Scholar
• Shannahan, J. H., A. J. Ghio, M. C. Schladweiler, J. K. McGee, J. H. Richards, S. H. Gavett, and U. P. Kodavanti. 2011. The role of iron in Libby amphibole-induced acute lung injury and inflammation. Inhal Toxicol 23:313–23. doi:10.3109/08958378.2011.569587.
   PubMed Web of Science ®Google Scholar
• Smith, M. J., and B. Naylor. 1972. A method for extracting ferruginous bodies from sputum and pulmonary tissue. Am. J. Clin. Pathol. 58:250–54. doi:10.1093/ajcp/58.3.250.
   PubMed Web of Science ®Google Scholar
• Thompson, J. K., M. B. MacPherson, S. L. Beuschel, and A. Shukla. 2017. Asbestos-induced mesothelial to fibroblastic transition is modulated by the inflammasome. Am. J. Pathol. 187:665–78. doi:10.1016/j.ajpath.2016.11.008.
   PubMed Web of Science ®Google Scholar
• Travis, W. D., Brambilla, E., Nicholson, A. G., Yatabe, Y., Austin, J. H. M., Beasley, M. B., Chirieac, L. R., Dacic, S., Duhig, E., Flieder, D. B., et. 2015. The 2015 world health organization classification of lung tumors. J. Thoracic. Oncol. 10:1243–60. doi:10.1097/JTO.0000000000000630.
   Google Scholar
• Tunesi, S., D. Ferrante, D. Mirabelli, S. Andorno, M. Betti, G. Fiorito, S. Guarrera, E. Casalone, M. Neri, D. Ugolini, et al. 2015. Gene-asbestos interaction in malignant pleural mesothelioma susceptibility. Carcinogenesis 36:1129–35. doi:10.1093/carcin/bgv097.
   PubMed Web of Science ®Google Scholar
• Uhlen, M., Zhang, C., Lee, S., Sjöstedt, E., Fagerberg, L., Bidkhori, G., Benfeitas, R., Arif, M., Liu, Z., Edfors, F., et. al. 2017. A pathology atlas of the human cancer transcriptome. Science357. doi:10.1126/science.aan2507
   Google Scholar
• Wang, L. I., D. Neuberg, and D. C. Christiani. 2004. Asbestos exposure, manganese superoxide dismutase (MnSod) genotype, and lung cancer risk. J. Occup. Environ. Med. 46:556–64. doi:10.1097/01.jom.0000128155.86648.a4.
   PubMed Web of Science ®Google Scholar
• Wei, S., L.-E. Wang, M. K. McHugh, Y. Han, M. Xiong, C. I. Amos, M. R. Spitz, and Q. W. Wei. 2012. Genome-wide gene-environment interaction analysis for asbestos exposure in lung cancer susceptibility. Carcinogenesis 33:1531–37. doi:10.1093/carcin/bgs188.
   PubMed Web of Science ®Google Scholar
• Zhang, W. Z., J. J. Butler, and S. M. Cloonan. 2019. Smoking-induced iron dysregulation in the lung. Free Radic. Biol. Med. 133:238–47. doi:10.1016/j.freeradbiomed.2018.07.024:.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., J. Shi, X. Liu, L. Feng, Z. Gong, P. Koppula, K. Sirohi, X. Li, Y. Wei, H. Lee, et al. 2018. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat. Cell Biol. 20:1181–92. doi:10.1038/s41556-018-0178-0.
   PubMed Web of Science ®Google Scholar